175 related articles for article (PubMed ID: 31564868)
1. Ormeloxifene nanotherapy for cervical cancer treatment.
Chauhan N; Maher DM; Hafeez BB; Mandil H; Singh MM; Yallapu MM; Jaggi M; Chauhan SC
Int J Nanomedicine; 2019; 14():7107-7121. PubMed ID: 31564868
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Khan S; Chauhan N; Yallapu MM; Ebeling MC; Balakrishna S; Ellis RT; Thompson PA; Balabathula P; Behrman SW; Zafar N; Singh MM; Halaweish FT; Jaggi M; Chauhan SC
Biomaterials; 2015; 53():731-43. PubMed ID: 25890768
[TBL] [Abstract][Full Text] [Related]
3. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
Chauhan N; Maher DM; Yallapu MM; B Hafeez B; Singh MM; Chauhan SC; Jaggi M
Sci Rep; 2019 Jul; 9(1):10917. PubMed ID: 31358785
[TBL] [Abstract][Full Text] [Related]
4. Ormeloxifene efficiently inhibits ovarian cancer growth.
Maher DM; Khan S; Nordquist JL; Ebeling MC; Bauer NA; Kopel L; Singh MM; Halaweish F; Bell MC; Jaggi M; Chauhan SC
Cancer Lett; 2015 Jan; 356(2 Pt B):606-12. PubMed ID: 25306892
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.
Sims LB; Curry KC; Parupalli S; Horner G; Frieboes HB; Steinbach-Rankins JM
Pharm Res; 2019 Mar; 36(5):66. PubMed ID: 30868271
[TBL] [Abstract][Full Text] [Related]
6. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
10. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
12. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
[TBL] [Abstract][Full Text] [Related]
13. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
14. Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells.
Chauhan N; Kruse A; Newby H; Jaggi M; Yallapu MM; Chauhan SC
ACS Omega; 2020 Jan; 5(2):1147-1156. PubMed ID: 31984272
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Nanoformulation for Cervical Cancer Treatment.
Zaman MS; Chauhan N; Yallapu MM; Gara RK; Maher DM; Kumari S; Sikander M; Khan S; Zafar N; Jaggi M; Chauhan SC
Sci Rep; 2016 Feb; 6():20051. PubMed ID: 26837852
[TBL] [Abstract][Full Text] [Related]
17. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
18. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
19. Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus.
Awasthi S; Daverey A; Dwivedi A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):208-14. PubMed ID: 17553677
[TBL] [Abstract][Full Text] [Related]
20. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
Wahane A; Malik S; Shih KC; Gaddam RR; Chen C; Liu Y; Nieh MP; Vikram A; Bahal R
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45244-45258. PubMed ID: 34524806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
